Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Ringborg

Showing results (141-150 of 158) with videos related to

Pageof 16
Sort By:
European Journal of Cancer (Oxford, England : 1990)|October 1, 1996
Comparison of induction chemotherapy before radiotherapy with radiotherapy only in patients with locally advanced squamous cell carcinoma of the lung. The Swedish Lung Cancer Study GroupO Brodin, E Nou, C Mercke, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 23, 2005
Hadrontherapy with carbon12: radiotherapy of the near futureT Auberger, J Debus, J P Gérard, et al.
Princess Takamatsu Symposia|January 1, 1990
Glutathione-linked enzymes in normal and tumor cells and their role in resistance against genotoxic agentsB Mannervik, K Berhane, V M Castro, et al.
Melanoma Research|April 1, 1996
Prognostic value of serum analyses of S-100 beta protein in malignant melanomaE von Schoultz, L O Hansson, E Djureen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 7, 2001
Serum S-100b protein as a prognostic marker in malignant cutaneous melanomaE D Mårtenson, L O Hansson, B Nilsson, et al.
Journal of Medical Screening|January 1, 1996
Screening for cutaneous malignant melanoma: a feasibility studyS Törnberg, E Månsson-Brahme, D Lindén, et al.
Journal of the National Cancer Institute|May 21, 1997
Screening of germline mutations in the CDKN2A and CDKN2B genes in Swedish families with hereditary cutaneous melanomaA Platz, J Hansson, E Månsson-Brahme, et al.
Cancer|May 1, 1996
Resection margins of 2 versus 5 cm for cutaneous malignant melanoma with a tumor thickness of 0.8 to 2.0 mm: randomized study by the Swedish Melanoma Study GroupU Ringborg, R Andersson, J Eldh, et al.
Melanoma Research|December 1, 1994
Elective lymph node dissection in stage I cutaneous malignant melanoma of the head and neck. A report from the Swedish Melanoma Study GroupJ Hansson, U Ringborg, B Lagerlöf, et al.
Cancer|February 1, 1993
Cutaneous malignant melanoma of the head and neck. Analysis of treatment results and prognostic factors in 581 patients: a report from the Swedish Melanoma Study GroupU Ringborg, L E Afzelius, B Lagerlöf, et al.
Pageof 16

Showing results (141-150 of 158) with videos related to

Sort By:
Pageof 16
European Journal of Cancer (Oxford, England : 1990)|October 1, 1996
Comparison of induction chemotherapy before radiotherapy with radiotherapy only in patients with locally advanced squamous cell carcinoma of the lung. The Swedish Lung Cancer Study GroupO Brodin, E Nou, C Mercke, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 23, 2005
Hadrontherapy with carbon12: radiotherapy of the near futureT Auberger, J Debus, J P Gérard, et al.
Princess Takamatsu Symposia|January 1, 1990
Glutathione-linked enzymes in normal and tumor cells and their role in resistance against genotoxic agentsB Mannervik, K Berhane, V M Castro, et al.
Melanoma Research|April 1, 1996
Prognostic value of serum analyses of S-100 beta protein in malignant melanomaE von Schoultz, L O Hansson, E Djureen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 7, 2001
Serum S-100b protein as a prognostic marker in malignant cutaneous melanomaE D Mårtenson, L O Hansson, B Nilsson, et al.
Journal of Medical Screening|January 1, 1996
Screening for cutaneous malignant melanoma: a feasibility studyS Törnberg, E Månsson-Brahme, D Lindén, et al.
Journal of the National Cancer Institute|May 21, 1997
Screening of germline mutations in the CDKN2A and CDKN2B genes in Swedish families with hereditary cutaneous melanomaA Platz, J Hansson, E Månsson-Brahme, et al.
Cancer|May 1, 1996
Resection margins of 2 versus 5 cm for cutaneous malignant melanoma with a tumor thickness of 0.8 to 2.0 mm: randomized study by the Swedish Melanoma Study GroupU Ringborg, R Andersson, J Eldh, et al.
Melanoma Research|December 1, 1994
Elective lymph node dissection in stage I cutaneous malignant melanoma of the head and neck. A report from the Swedish Melanoma Study GroupJ Hansson, U Ringborg, B Lagerlöf, et al.
Cancer|February 1, 1993
Cutaneous malignant melanoma of the head and neck. Analysis of treatment results and prognostic factors in 581 patients: a report from the Swedish Melanoma Study GroupU Ringborg, L E Afzelius, B Lagerlöf, et al.
Pageof 16